NILA Urges OMB to Reconsider FDA's Proposed Rules Regulating LDTs

NILA is urging the White House to reconsider releasing the proposed rules allowing the Food and Drug Administration (FDA) to regulate Laboratory Developed Tests (LDTs).

Read NILA’s September 18, 2023, letter to the Office of Management and Budget (OMB). (pdf).